Cooper Companies (NASDAQ:COO) Upgraded to “Buy” at StockNews.com

Cooper Companies (NASDAQ:COO) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday.

Other equities analysts also recently issued reports about the stock. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 target price (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and raised their price target for the stock from $107.00 to $115.00 in a research note on Tuesday, July 16th. Morgan Stanley boosted their price objective on Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday, September 10th. Finally, Wells Fargo & Company increased their target price on Cooper Companies from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, August 29th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Price Performance

NASDAQ:COO opened at $103.75 on Friday. The firm has a market capitalization of $20.66 billion, a price-to-earnings ratio of 57.80, a PEG ratio of 2.24 and a beta of 0.99. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.99 and a quick ratio of 1.18. The business has a 50 day simple moving average of $107.30 and a 200-day simple moving average of $97.58. Cooper Companies has a 1 year low of $80.48 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. During the same period in the previous year, the firm earned $0.84 earnings per share. Cooper Companies’s quarterly revenue was up 7.8% compared to the same quarter last year. Equities analysts forecast that Cooper Companies will post 3.65 EPS for the current year.

Insider Activity at Cooper Companies

In other news, COO Daniel G. Mcbride sold 114,992 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at $520,488.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares in the company, valued at $4,714,534.08. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 over the last three months. 2.00% of the stock is owned by corporate insiders.

Institutional Trading of Cooper Companies

A number of institutional investors have recently modified their holdings of COO. Vanguard Group Inc. raised its stake in shares of Cooper Companies by 303.0% during the 1st quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock worth $2,343,723,000 after acquiring an additional 17,367,502 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its stake in Cooper Companies by 3.0% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 7,820,590 shares of the medical device company’s stock valued at $682,738,000 after acquiring an additional 231,155 shares in the last quarter. Capital World Investors grew its holdings in Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock worth $573,657,000 after purchasing an additional 4,246,519 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after purchasing an additional 737,726 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of Cooper Companies by 279.8% during the 1st quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock valued at $348,723,000 after purchasing an additional 2,532,186 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.